| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/1992 | EP0483063A1 Ergoline derivatives |
| 04/29/1992 | EP0482993A1 N,O-Spirocyclic derivatives of cyclotriphosphazenes, their preparation and their therapeutical use |
| 04/29/1992 | EP0482948A1 A medicament composition containing 6-substituted alkoxy quinoxaline derivative and its production |
| 04/29/1992 | EP0482939A1 Isoquinolinone derivative |
| 04/29/1992 | EP0482931A1 Benzopyran derivatives having anti-hypertensive and vasodilatory activity, their preparation and their therapeutic use |
| 04/29/1992 | EP0482919A2 Method and composition for treating leg weakness in fowl by the administration of a non-steroidal anti-inflammatory drug |
| 04/29/1992 | EP0482804A1 Pyrrolo[2,3-d]pyrimidines with cardiovascular activity, process for their preparation and pharmaceutical compositions containing them |
| 04/29/1992 | EP0482797A1 Inhibitors of HIV protease |
| 04/29/1992 | EP0482795A1 Preparation of novel invermectin compounds |
| 04/29/1992 | EP0482771A2 Heterocyclic acids |
| 04/29/1992 | EP0482717A1 Use of a benzo[b]thiophene-2-carboximidamide derivative against heart failure |
| 04/29/1992 | EP0482715A1 Nutritional composition |
| 04/29/1992 | EP0482696A1 4-[4- or 6-(Trifluoromethyl-2-pyridinyl)]-1-piperazinyl-alkyl substituted lactams |
| 04/29/1992 | EP0482594A1 Tylosin derivative and method for preparing the same |
| 04/29/1992 | EP0482580A1 Antidiarrheal compositions |
| 04/29/1992 | EP0482543A1 Oasomycine, method of its preparation and its use |
| 04/29/1992 | EP0482498A2 Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor |
| 04/29/1992 | EP0482493A2 Pharmaceutical compositions active in the therapy of neurological affections in aids patients, containing as an active principle at last one compound selected from the group consisting of S-adenosyl-L-methionine salt, 5-methyl-tetrahydrofolic acid, 5-formyltetrahydrofolic acid |
| 04/29/1992 | EP0482481A1 Method for the preparation of 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepines |
| 04/29/1992 | EP0482345A1 Nutritive composition and process for preparing the same |
| 04/29/1992 | EP0482342A2 Hypocholesterolemic unsymmetrical dithiol ketals |
| 04/29/1992 | EP0482208A1 Pyridazinone derivative |
| 04/29/1992 | EP0482175A1 Fault tolerant computer system. |
| 04/29/1992 | EP0482172A1 Anti-tumor agents having reduced toxicity on the basis of cytostatic agents and xanthogenates |
| 04/29/1992 | EP0482084A1 (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives. |
| 04/29/1992 | EP0482071A1 New antiviral agents |
| 04/29/1992 | EP0481994A1 Metallo-organic cobalt compounds and uses thereof |
| 04/29/1992 | EP0409903B1 Process for preparing polyunsaturated fatty acids |
| 04/29/1992 | EP0201537B1 Novel use of anti-nausea and anti-emetic pharmazeutical agents. |
| 04/29/1992 | EP0092574B1 Oligonucleotide therapeutic agent and methods of making same |
| 04/29/1992 | CN1060655A 4-or 5-substituled pyridine-2-carboxylic acids process for preparation thereof and use therof as pharmaceuticals |
| 04/29/1992 | CN1060653A Crystallization of optical isomers of leukotriene antagonists |
| 04/29/1992 | CN1060652A Oxamides |
| 04/29/1992 | CN1060610A Making method of high-content tea alkali control releasing agent |
| 04/29/1992 | CN1060599A 化妆品组合物 Cosmetic composition |
| 04/29/1992 | CN1016420B Dihydrobenzofuran-and chromancarboxamide derivatives, processes for the preparation thereof and use thereof as neuroleptics |
| 04/28/1992 | US5109132 Process for the preparation of 3-exomethylene cepham derivatives |
| 04/28/1992 | US5109025 Therapeutic agent for penal disorders |
| 04/28/1992 | US5109021 Prostaglandin analogues, process for their preparation and pharmaceutical compositions containing them |
| 04/28/1992 | US5109016 Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions |
| 04/28/1992 | US5109011 Analgesics |
| 04/28/1992 | US5109008 Pharmaceutically useful furo[3,2-c]pyridines |
| 04/28/1992 | US5109007 Attenuation of ethyl alcohol intoxication with alpha-2 adrenoceptor antagonists |
| 04/28/1992 | US5109006 Certain pharmaceutically active 6H-imidazo[1,2-a]pyridine-5-ones |
| 04/28/1992 | US5109005 Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders |
| 04/28/1992 | US5109003 Method for the treatment of peptic ulcer disease |
| 04/28/1992 | US5109002 Antipsychotic 1-cycloalkylpiperidines |
| 04/28/1992 | US5109001 Treating hyperactivity of excitatory neurotransmitters |
| 04/28/1992 | US5108998 Cardiotonic thiadiazine derivatives |
| 04/28/1992 | US5108997 Cephem compounds |
| 04/28/1992 | US5108996 Antiinflammatory agents |
| 04/28/1992 | US5108995 Repeating cycles of unit dosage of combination of estrogen and progestin; contraceptive |
| 04/28/1992 | US5108994 Antiviral purine derivatives |
| 04/28/1992 | US5108993 Pharmaceutical composition comprising zidovudine and inosiplex or components thereof for the treatment of aids-related syndromes |
| 04/28/1992 | US5108992 Macrolide compounds |
| 04/28/1992 | US5108991 Useful for carrying therapeutical agents through skin and other body membranes |
| 04/28/1992 | US5108921 Method for enhanced transmembrane transport of exogenous molecules |
| 04/28/1992 | US5108757 Sustained release of nifedipine |
| 04/28/1992 | US5108754 Orthomolecular method of treating sickle cell disease |
| 04/28/1992 | US5108747 Stable oxpenem-3-carboxylic acids as beta-lactamase inhibitors |
| 04/28/1992 | US5108741 Applying to infected area of human toes to cure athlete's foot |
| 04/28/1992 | US5108363 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
| 04/28/1992 | CA1299583C Effervescent couples, histamine h -antagonist effervescent compositions containing them and their preparation |
| 04/28/1992 | CA1299579C2 Benzamides, preparation process and therapeutic use |
| 04/28/1992 | CA1299578C Indane derivatives, their preparation process and novel intermediates thus obtained, their application as medicines and compositions containing same |
| 04/28/1992 | CA1299575C Phosphate ester derivatives, and their use as anti-cancer agents |
| 04/28/1992 | CA1299574C (1)-1.beta.-ETHYL-1.alpha.-HYDROXYMETHYL-1,2,3,4,6,7,12,12-.beta. .alpha.-OCTAHYDROINDOLO ¬2,3-A| QUINOLIZINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| 04/28/1992 | CA1299572C Lipophilic quaternary ammonium salicylates and their use in cosmetology and skin pharmacy |
| 04/28/1992 | CA1299571C 2-aminoacetamide pyridinyl derivatives |
| 04/28/1992 | CA1299567C Esperamicin derivatives |
| 04/28/1992 | CA1299566C 2.beta.-SUBSTITUTED-METHYL-PENICILLANIC ACID DERIVATIVES, AND SALTS AND ESTERS THEREOF |
| 04/28/1992 | CA1299565C Penem compounds, production and use thereof |
| 04/28/1992 | CA1299564C Cephalosporin derivative |
| 04/27/1992 | WO1992007554A1 Implantable biodegradable material and method for producing same |
| 04/27/1992 | CA2054240A1 Use of benzo[b]thiophene-2-carboximidamide derivative |
| 04/27/1992 | CA2054232A1 Oasomycins, a process for the preparation thereof and the use thereof |
| 04/27/1992 | CA2054225A1 8-azabicyclo[3.2.1] octylalkylthiazolidinones, a process for their preparation and their use as medicaments |
| 04/27/1992 | CA2052988A1 Nutritional composition and a process for its production |
| 04/26/1992 | CA2053800A1 Tylosin derivative and method for preparing the same |
| 04/25/1992 | CA2054091A1 Isoquinolinone derivatives |
| 04/25/1992 | CA2054034A1 7-cycloalkylimidazodiazepines and the salts thereof; process for preparing the same and intermediates produced; their use as drugs; pharmaceutical compositions containing them |
| 04/25/1992 | CA2054017A1 Antidiarrheal compositions |
| 04/25/1992 | CA2053945A1 Method and composition for treating leg weakness in fowl |
| 04/25/1992 | CA2053928A1 Benzopyran derivatives having anti-hypertensive and vasodilartory activity, their preparation and their therapeutic use |
| 04/24/1992 | WO1992006958A1 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist |
| 04/24/1992 | CA2072598A1 Pharmaceutical compositions |
| 04/24/1992 | CA2053980A1 4-[4- or 6-(trifluoromethyl-2-pyridinyl)]-1-piperazinyl-alkyl substituted lactams |
| 04/24/1992 | CA2053791A1 Process for the preparation of racemic pilosinine derivatives |
| 04/23/1992 | WO1992006709A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 04/23/1992 | DE4033567A1 Use of di:carboxylic acid mono:ester(s) |
| 04/23/1992 | DE4033565A1 Use of phenol derivs. - as anti-seborrhoeic agents in prodn. of prepn(s). for treatment of psoriasis, acne, etc. |
| 04/23/1992 | DE4033563A1 New use of furoic and thiophenic acid derivs. - as anti-seborrhoeic agents in prodn. of prepn(s) for treatment of acne, dandruff, etc. |
| 04/23/1992 | DE4033562A1 Use of benzoic acid derivs. as anti-seborrhoeic agent - in treatment of acne, psoriasis or dandruff |
| 04/23/1992 | DE4033530A1 Crystallisation inhibitor for treating kidney stone disorders - contains an ethanolic extract of madder contg. 0.2-1.0 per cent ruberythric acid |
| 04/23/1992 | DE4033524A1 1-(Tert.-butylamino)-3-((6-chloro-m-tolyl)-oxy)-2-propanol - for transdermal use to reduce total cholesterol content and for treatment of atherosclerosis |
| 04/23/1992 | DE4033445A1 Pour-on formulation against endo-parasites for dogs and cats - comprises levamisole or tetramisole in N-methyl:pyrrolidine, has good penetration without damage to skin |
| 04/23/1992 | CA2094588A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 04/23/1992 | CA2053772A1 Benzolactam analogs as antagonists of cck |
| 04/23/1992 | CA2053159A1 Antibiotic c-3 cyclobutenedione substituted (1-carba) cephalosporin compounds, compositions, and methods of use thereof |
| 04/23/1992 | CA2028220A1 Azoxy compounds |